Resources
Renal facility design guidelines for remote areas
Renal facility design guidelines developed to inform the infrastructure builds of the renal dialysis units under the Better Renal Services for First Nations People Budget Measure.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 16 April 2024
This communique provides a summary of the advisory committee's meeting on 16 April 2024.
40:53
Community Dialysis Unit Expression of Interest information webinar – 18 March 2024
Webinar held on 18 March 2024, hosted by the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Department of Health and Aged Care. The webinar focussed on improving access to dialysis treatments for First Nations Australians in remote communities.
Community Dialysis Unit Expression of Interest – fact sheet and FAQs
We are funding 30 dialysis units to provide life-saving health care for First Nations Australians with kidney disease. Communities are invited to self-identify dialysis need through an EOI process, as outlined by this fact sheet.
Expression of Interest form – Community Dialysis Unit
We are funding 30 dialysis units to provide life-saving health care for First Nations Australians with kidney disease. Communities are invited to self-identify dialysis need by completing this expression of interest form.
Better Renal Services Steering Committee communique – 20 February 2024
An update from the Better Renal Services Steering Committee after their meeting on 20 February 2024.
Endometriosis Progress Report 2024
This report provides an update on the progress of the National Action Plan for Endometriosis.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 13 February 2024
This communique provides a summary of the advisory committee's meeting on 13 February 2024.
56:38
Dedication ceremony and unveiling of the National Site of Recognition for Thalidomide Survivors
The National Site of Recognition for Thalidomide Survivors and their Families acknowledges the thalidomide tragedy in Australia. It serves as a lasting reminder to all Australians that the lessons of the tragedy must never be forgotten.
Life Saving Drugs Program (LSDP) Expert Panel meeting agenda – 16 February 2024
Life Saving Drugs Program (LSDP) Expert Panel (the panel) agenda for the 17th meeting on 16 February 2024.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 8 December 2023
This communique provides a summary of the advisory committee's meeting on 8 December 2023.
Better Renal Services Steering Committee communique – 4 December 2023
An update from the Better Renal Services Steering Committee after their meeting on 4 December 2023.
Dedication Ceremony for the National Site of Recognition for Thalidomide and their Families – Program Booklet
The National Site of Recognition was dedicated by the Minister for Health and Aged Care, along with thalidomide survivors and their families, on 30 November 2023. This is the program booklet from the ceremony.
National Governance Framework for Cancer and Population Screening
The National Governance Framework for Cancer and Population Screening outlines the governance arrangements of our various committees and groups.
Better Renal Services Steering Committee communique – 26 September 2023
An update from the Better Renal Services Steering Committee after their meeting on 26 September 2023.
National Site of Recognition Steering Committee communique – September 2023
Details of the sixth meeting of Steering Committee for the National Site of Recognition for thalidomide survivors and their families.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 3 October 2023
This communique provides a summary of the advisory committee's meeting on 3 October 2023.
Application Form B for Conditions other than Group 1 – Inborn Errors of Metabolism
Application for Australian Government financial assistance for individuals with Inborn Errors of Metabolism (other than DHPR, hyperphenylalaninemia and PKU).
Application Form C – Change of details – Inborn Errors of Metabolism
Individuals registered with the Inborn Errors of Metabolism program can use this form to change their personal information.
Application to register as an Approved Metabolic Specialist – Inborn Errors of Metabolism
Specialist doctors can use this form to apply for registration as an approved metabolic specialist under the Inborn Errors of Metabolism (IEM) program.
National Strategy for Health Practitioner Pain Management Education
The National Pain Management Health Practitioner Education Strategy was launched on 6 October 2023. The strategy was developed by the Faculty of Pain Medicine (FPM), Australian and New Zealand College of Anaesthetists (ANZCA) with funding from the Australian Government.
Life Saving Drugs Program (LSDP) Expert Panel meeting agenda – 20 October 2023
Life Saving Drugs Program (LSDP) Expert Panel (the panel) agenda for the 16th meeting on 20 October 2023.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 23 August 2023
This communique provides a summary of the advisory committee's meeting on 23 August 2023.
National Site of Recognition Steering Committee communique – 10 July 2023
Details of the fifth meeting of Steering Committee for the National Site of Recognition for thalidomide survivors and their families, held on 10 July 2023.
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 21 July 2023
This communique provides a summary of the advisory committee's meeting on 21 July 2023.
Date last updated: